LBL-047

· Nanjing Leads Biolabs Co.,Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LBL-047, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus [Phase 1]